Christofides A - Search Results

1

Harmonization of PD-L1 testing in oncology: a Canadian pathology perspective.

Ionescu DN, Downes MR, Christofides A, Tsao MS. Ionescu DN, et al. Among authors: christofides a. Curr Oncol. 2018 Jun;25(3):e209-e216. doi: 10.3747/co.25.4031. Epub 2018 Jun 28. Curr Oncol. 2018. PMID: 29962847 Free PMC article. Review.

2

A Canadian guideline on the use of next-generation sequencing in oncology.

Yip S, Christofides A, Banerji S, Downes MR, Izevbaye I, Lo B, MacMillan A, McCuaig J, Stockley T, Yousef GM, Spatz A. Yip S, et al. Among authors: christofides a. Curr Oncol. 2019 Apr;26(2):e241-e254. doi: 10.3747/co.26.4731. Epub 2019 Apr 1. Curr Oncol. 2019. PMID: 31043833 Free PMC article.

3

Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian Perspective.

Ferrario C, Christofides A, Joy AA, Laing K, Gelmon K, Brezden-Masley C. Ferrario C, et al. Among authors: christofides a. Curr Oncol. 2022 Apr 13;29(4):2720-2734. doi: 10.3390/curroncol29040222. Curr Oncol. 2022. PMID: 35448196 Free PMC article. Review.

4

[No title available]

[No authors listed] [No authors listed] PMID: 33704127

5

Canadian perspective on managing multiple myeloma during the COVID-19 pandemic: lessons learned and future considerations.

Foley R, Kaedbey R, Song K, Venner CP, White D, Doucette S, Christofides A, Reece DE. Foley R, et al. Among authors: christofides a. Curr Oncol. 2020 Oct;27(5):270-274. doi: 10.3747/co.27.7149. Epub 2020 Oct 1. Curr Oncol. 2020. PMID: 33173379 Free PMC article.

6

A Canadian Perspective on the Challenges for Delivery of Curative-Intent Therapy in Stage III Unresectable Non-Small Cell Lung Cancer.

Brade A, Jao K, Yu S, Cheema P, Doucette S, Christofides A, Schellenberg D. Brade A, et al. Among authors: christofides a. Curr Oncol. 2021 Apr 24;28(3):1618-1629. doi: 10.3390/curroncol28030151. Curr Oncol. 2021. PMID: 33923355 Free PMC article.

7

A Canadian Perspective: Monoclonal Antibodies for Pre- and Post-Exposure Protection from COVID-19 in Vulnerable Patients with Hematological Malignancies.

Owen C, Robinson S, Christofides A, Sehn LH. Owen C, et al. Among authors: christofides a. Curr Oncol. 2022 May 31;29(6):3940-3949. doi: 10.3390/curroncol29060315. Curr Oncol. 2022. PMID: 35735424 Free PMC article. Review.

8

A Canadian perspective on the subcutaneous administration of rituximab in non-Hodgkin lymphoma.

MacDonald D, Crosbie T, Christofides A, Assaily W, Wiernikowski J. MacDonald D, et al. Among authors: christofides a. Curr Oncol. 2017 Feb;24(1):33-39. doi: 10.3747/co.24.3470. Epub 2017 Feb 27. Curr Oncol. 2017. PMID: 28270723 Free PMC article. Review.

9

Emerging therapies for the treatment of relapsed or refractory diffuse large B cell lymphoma.

Skrabek P, Assouline S, Christofides A, MacDonald D, Prica A, Sangha R, Matthews BA, Sehn LH. Skrabek P, et al. Among authors: christofides a. Curr Oncol. 2019 Aug;26(4):253-265. doi: 10.3747/co.26.5421. Epub 2019 Aug 1. Curr Oncol. 2019. PMID: 31548805 Free PMC article. Review.

10

Update on the subcutaneous administration of rituximab in Canadian cancer centres.

Stewart D, Aucoin JS, Crosbie T, Forman M, Lye E, Christofides A, Mitha A. Stewart D, et al. Among authors: christofides a. Curr Oncol. 2020 Apr;27(2):113-116. doi: 10.3747/co.27.6041. Epub 2020 May 1. Curr Oncol. 2020. PMID: 32489254 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters